CellWise reads gene expression at single-cell resolution and interprets it through peer-reviewed frameworks, so the story it tells is grounded in the biology rather than a black box.
A standard panel measures analytes in bulk fluid. Single-cell reads the cells themselves.
Standard blood work can tell you inflammation is elevated, but not which cells are inflamed, why they are dysregulated, or how they will respond to a therapy. DNA sequencing adds inherited risk but says nothing about real-time expression.
CellWise reads gene expression across immune cell populations, localizing the signal to the cells responsible and capturing the dynamic expression that adapts to lifestyle, environment, and treatment.
Every read is anchored to peer-reviewed frameworks, not a proprietary score no one can check.
A single-cell immune-aging clock that identifies which immune compartments are aging fastest from one PBMC sample.
The 125-gene cellular-senescence panel, read at single-cell resolution across the immune compartment.
The canonical hallmarks framework, mapped onto the patient's own cell-resolved biology.
The glycolytic/inflammatory to oxidative/quiescent axis across cell types, a primary determinant of how a patient responds.
The statistics that keep a real anomaly from being averaged out of existence.
CellWise is built and deployed, and being validated in the open with our design partners.
CellWise is a software-as-a-medical-device on a clearance pathway. Today it is for research use until SaMD clearance, and we say so on every page.
A structured validation program is running across the beta cohort, building the real-world evidence base sample by sample.
Design partners contribute real-world cases that sharpen the models and become the evidence that supports clearance.